Inventor · disambiguated record
Iris Pecker
Also filed as: PECKER IRIS
26 granted patents·19 pending applications·411 citations·filing 1997–2025
97Inventor score
Files withINSIGHT STRATEGY & MARKETING14INSIGHT BIOPHARMACEUTICALS LTD10HADASIT MED RES SERVICE5KAHR MEDICAL LTD4INSIGHT STRATEGY MARKETING LTD1
Top patents by PatentIndex Score
45 records- 0190US5968822APolynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cellsFiled 1997·Granted Oct 19, 1999·75 cites·30 claims
- 0289US6475763B1Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying sameINSIGHT STRATEGY & MARKETING·Filed 2000·Granted Nov 5, 2002·30 cites·8 claims
- 0388US6960471B2Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cellsHADASIT MED RES SERVICE·Filed 2003·Granted Nov 1, 2005·11 cites·27 claims
- 0487US6790658B2Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cellsINSIGHT BIOPHARMACEUTICALS LTD·Filed 2001·Granted Sep 14, 2004·11 cites·31 claims
- 0587US6190875B1Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probeINSIGHT STRATEGY & MARKETING·Filed 1998·Granted Feb 20, 2001·92 cites·61 claims
- 0684US6426209B1Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying sameINSIGHT STRATEGY MARKETING LTD·Filed 2000·Granted Jul 30, 2002·12 cites·4 claims
- 0782US6800441B2Heparanase specific molecular probes and their use in research and medical applicationsINSIGHT BIOPHARMACEUTICALS LTD·Filed 2001·Granted Oct 5, 2004·12 cites·1 claims
- 0881US8048993B2Heparanase specific molecular probes and their use in research and medical applicationsINSIGHT BIOPHARMACEUTICALS LTD·Filed 2008·Granted Nov 1, 2011·4 cites·12 claims
- 0981US6699672B1Heparanase specific molecular probes and their use research and medical applicationsINSIGHT BIOPHARMACEUTICALS LTD·Filed 2000·Granted Mar 2, 2004·13 cites·14 claims
- 1080US7423139B2High level expression of recombinant human erythropoietin having a modified 5′-UTRINSIGHT BIOPHARMACEUTICALS LTD·Filed 2004·Granted Sep 9, 2008·4 cites·11 claims
- 1180US6348344B1Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying sameINSIGHT STRATEGY & MARKETING·Filed 1999·Granted Feb 19, 2002·32 cites·95 claims
- 1279US7049407B2Heparanase specific antibodies and their use in research and medical applicationsHADASIT MED RES SERVICE·Filed 2001·Granted May 23, 2006·8 cites·12 claims
- 1379US6177545B1Heparanase specific molecular probes and their use in research and medical applicationsINSIGHT STRATEGY & MARKETING·Filed 1998·Granted Jan 23, 2001·30 cites·10 claims
- 1479US2025026809A1SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2024·Application pending·0 cites
- 1578US6986996B2Heparanase specific molecular probes and their use in research and medical applicationsHADASIT MED RES SERVICE·Filed 2004·Granted Jan 17, 2006·7 cites·1 claims
- 1674US6946131B2Heparanase activity neutralizing anti-heparanase monoclonal antibodyHADASIT MED RES SERVICE·Filed 2003·Granted Sep 20, 2005·7 cites·6 claims
- 1773US12134638B2SIRPalpha-4-1BBL variant fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2019·Granted Nov 5, 2024·0 cites·10 claims
- 1872US6562950B2Heparanase activity neutralizing anti-heparanase monoclonal antibodyINSIGHT STRATEGY & MARKETING·Filed 1998·Granted May 13, 2003·28 cites·27 claims
- 1970US7101706B1Polynucleotides and polypeptides encoded thereby distantly homologous to heparanaseINSIGHT BIOPHARMACEUTICALS LTD·Filed 2000·Granted Sep 5, 2006·3 cites·3 claims
- 2067US7893240B2High level expression of recombinant human erythropoietin having a modified 5′-UTRINSIGHT BIOPHARMACEUTICALS LTD·Filed 2008·Granted Feb 22, 2011·0 cites·2 claims
- 2167US6531129B2Heparanase specific molecular probes and their use in research and medical applicationsINSIGHT STRATEGY & MARKETING·Filed 1999·Granted Mar 11, 2003·16 cites·6 claims
- 2266US2009275106A1Polynucleotide encoding A polypeptide having heparanase activity and expression of same in genetically modified cellsINSIGHT STRATEGY & MARKETING·Filed 2007·Application pending·0 cites
- 2365US2004142427A1Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cellsFiled 2004·Application pending·0 cites
- 2464US2025163133A1SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2025·Application pending·0 cites
- 2563US6664105B1Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cellsINSIGHT STRATEGY & MARKETING·Filed 1999·Granted Dec 16, 2003·15 cites·5 claims
- 2662US6677137B2Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activityINSIGHT STRATEGY & MARKETING·Filed 2001·Granted Jan 13, 2004·1 cites·16 claims
- 2761US2004146497A1Therapeutic and cosmetic uses of heparanasesFiled 2004·Application pending·0 cites
- 2860US2005260187A1Therapeutic and cosmetic uses of heparanasesHADASIT MED RES SERVICE·Filed 2005·Application pending·0 cites
- 2959US2003068806A1Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying sameFiled 2002·Application pending·0 cites
- 3058US7790376B2Heparanase specific molecular probes and their use in research and medical applicationsINSIGHT BIOPHARMACEUTICALS LTD·Filed 2004·Granted Sep 7, 2010·0 cites·2 claims
- 3158US2003161823A1Therapeutic and cosmetic uses of heparanasesFiled 2003·Application pending·0 cites
- 3257US7666651B2Polypeptide having heparanase activityINSIGHT BIOPHARMACEUTICALS LTD·Filed 2001·Granted Feb 23, 2010·0 cites·2 claims
- 3357US2004213789A1Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodiesFiled 2003·Application pending·0 cites
- 3455US2004170631A1Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodiesFiled 2003·Application pending·0 cites
- 3554US7339038B2Heparanase specific molecular probes and their use in research and medical applicationsINSIGHT BIOPHARMACEUTICALS LTD·Filed 2003·Granted Mar 4, 2008·0 cites·9 claims
- 3652US2006269552A1Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodiesYACOBY-ZEEVI ORON·Filed 2004·Application pending·0 cites
- 3752US2005070000A1Polynucleotides and polypeptides encoded thereby distantly homologous to heparanaseFiled 2004·Application pending·0 cites
- 3851US12286466B2PD1-4-1BBL variant fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2019·Granted Apr 29, 2025·0 cites·13 claims
- 3951US2006223108A1Methods and kits for diagnosing and monitoring hematopoietic cancersINSIGHT STRATEGY & MARKETING·Filed 2006·Application pending·0 cites
- 4051US2003236215A1Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cellsINSIGHT STRATEGY & MARKETING·Filed 2003·Application pending·0 cites
- 4149US2003180788A1Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activityINSIGHT STRATEGY & MARKETING·Filed 2003·Application pending·0 cites
- 4245US2003148321A1Methods and kits for diagnosing and monitoring hematopoietic cancersFiled 2002·Application pending·0 cites
- 4344US2002068054A1Therapeutic and cosmetic uses of heparanasesINSIGHT STRATEGY & MARKETING·Filed 2000·Application pending·0 cites
- 4437US2003217375A1Transgenic animals expressing heparanase and uses thereofZCHARIA EYAL·Filed 2003·Application pending·0 cites
- 4534US2002194625A1Transgenic animals expressing heparanase and its usesINSIGHT STRATEGY & MARKETING·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Iris Pecker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →